SCHEMBL32665005

SCHEMBL32665005

COC(=O)C1CN(c2ccc3nnc(-c4ccc(C)cc4)n3n2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 7/20 0.49
APAF1 O14727 2/20 0.49
HPGD P15428 8/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 5/20 0.48
POLB P06746 3/20 0.48
DPP4 P27487 5/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HSD17B10 Q99714 5/20 0.46
HTT P42858 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RECQL P46063 1/20 0.46
PIM1 P11309 2/20 0.46
TP53 P04637 1/20 0.45
TSHR P16473 2/20 0.45
ALOX15 P16050 1/20 0.45
MCL1 Q07820 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665398 0.91 ALDH1A1 (0.48) ALDH1A1KDM4EAPAF1HPGDGAA
SCHEMBL32665055 0.91 MAPT (0.54) ALDH1A1KDM4EAPAF1HPGDMAPT
SCHEMBL32665179 0.91 HPGD (0.54) ALDH1A1KDM4EAPAF1HPGDMAPT
SCHEMBL32665284 0.91 HSD17B10 (0.59) ALDH1A1KDM4EAPAF1HPGDGAA
SCHEMBL32665192 0.90 HSD17B10 (0.49) ALDH1A1KDM4EAPAF1HPGDGAA
SCHEMBL32664943 0.89 ALDH1A1 (0.53) ALDH1A1KDM4EAPAF1HPGDGAA
SCHEMBL32665223 0.86 MAPT (0.46) ALDH1A1KDM4EAPAF1HPGDMAPT
SCHEMBL32665487 0.82 MAPT (0.42) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL32665352 0.81 MAPT (0.57) ALDH1A1KDM4EAPAF1HPGDMAPT
SCHEMBL32664969 0.81 HSD17B10 (0.63) ALDH1A1KDM4EAPAF1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS UNIV MINNESOTA (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS NR5A1, CYP17A1, CNR1 ALDH1A1 663/4885KDM4E 1972/4885APAF1 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.